Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,009 public trials 298 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis

NCT02219932

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Research site Cullman, Alabama, United States
  • Research site Phoenix, Arizona, United States
  • Research site San Diego, California, United States
  • Research site Bradenton, Florida, United States
View all 87 locations
View Trial Details
Completed

Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)

NCT02776072

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Research Site Homewood, Alabama, United States
  • Research Site Gilbert, Arizona, United States
  • Research Site Hanford, California, United States
  • Research Site Modesto, California, United States
View all 121 locations
View Trial Details
Completed

Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis

NCT00469378

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Olomouc, Czechia
  • GSK Investigational Site Prague, Czechia
View Trial Details
Completed

Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis

NCT01480076

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Research Site Concord, New South Wales, Australia
  • Research Site Kogarah, New South Wales, Australia
  • Research Site Liverpool, New South Wales, Australia
  • Research Site New Lambton Heights, New South Wales, Australia
View all 59 locations
View Trial Details
Completed

BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis

NCT01156311

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Danbury, Connecticut, United States
  • Research Site Atlanta, Georgia, United States
View all 16 locations
View Trial Details
Completed

Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms

NCT01333501

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
Locations
  • Novartis Investigative Site Alzenau in Unterfranken, Germany
  • Novartis Investigative Site Bamberg, Germany
  • Novartis Investigative Site Leipzig, Germany
  • Novartis Investigative Site Würzburg, Germany
View all 26 locations
View Trial Details

Related conditions